banner USF Home College of Arts & Sciences OASIS myUSF USF A-Z Index

USF Home > College of Arts and Sciences > Cancer Biology Ph.D. Program

Jessica  McDaniel

Jessica McDaniel

Jessica McDaniel

  

Bio

fiogf49gjkf0d

Dr. Jessica McDaniel successfully defended her dissertation on August 24, 2012 and is pictured here with her committee. From left to right: Committee members Javier Pinilla-Ibarz and Sheng Wei; Dissertation Chair Neal Young, NIH; Jessica McDaniel; Major Professor P.K. Burnette; committee members Julie Djeu and Xue-Zhong Yu. Dr. McDaniel initially joined the Office of Technology Commercialization and Knowledge Transfer at Ohio State University as a postdoctoral licensing analyst. She is now a Senior MSL with Celgene.

Dr. McDaniel's publications while in the program:

McDaniel JM, Zou JX, Fulp W, Chen DT, List AF, Epling-Burnette PK.Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation.Leukemia. 2011 Dec 23. doi: 10.1038/leu.2011.359.

McDaniel JM, Pinilla-Ibarz J, Epling-Burnette PK. 2012, Molecular action of lenalidomide in lymphocytes and hematologic malignancies. Adv Hematol. July 2012:513702

Dr. McDaniel's publications since graduation:

Epling-Burnette PK, McDaniel J, Wei S, List AF. Emerging immunosuppressive drugs in myelodysplastic syndromes. Expert Opin Emerg Drugs. 2012 Dec;17(4):519-41. doi: 10.1517/14728214.2012.736487. Epub 2012 Nov 20. Review. PMID: 23163589

Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM, Kim E, Bebbington C, Baer M, Yarranton G, Lancet J, Komrokji RS, Abdel-Wahab O, List AF, Epling-Burnette PK. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 2013 Jun 20;121(25):5068-77. doi: 10.1182/blood-2012-10-460170. Epub 2013 Apr 30. PMID: 23632888